BT-001 (Botwick Biotechnology)

N/A

Report date: 2025/09/08 20:01:34

Base Information

Drug NameBT-001 (Botwick Biotechnology)
Drug Alias Name重组A型肉毒毒素（博特维克生物技术）
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsUpper limb spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Botwick Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Botwick Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsUpper limb spasticity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A